Immune Checkpoint Inhibitor (ICPI) Efficacy and Resistance Detected by Comprehensive Genomic Profiling (CGP) in Non-Small Cell Lung Cancer (NSCLC)

Ross J, Goldberg M, Albacker L, Gay L, Agarwala V, Elvin J, Vergillo J, Ramkissoon S, Severson E, Daniel S, Ali S, Schrock A, Frampton G, Fabrizio D, Miller V, Singal G, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Analyzing Biomarkers of Cancer Immunotherapy (CIT) Response Using a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, Li G, Gossai A, Albacker L, Goldberg M, He J, Frank S, Bourque D, Ivanov V, Fabrizio D, Caron T, Parker A, Guria A, Miller V, Elvin J, Ross J, Abernethy AP, Stephens P

September 2017

Abstract

ESMO Annual Congress

Use of Electronic Health Record Data for Quality Reporting

Abernethy AP, Gippetti J, Parulkar R, Revol C

August 2017

Manuscript

Journal of Oncology Practice

June 2017

Manuscript

PLoS One

June 2017

Abstract

ASCO Annual Meeting

Implementation of the IOM 13 Point Care Plan by OCM Practices

Fargnoli B, Jaffe N, Bauer-Levey N, Cowing K, Schneider J, Parulkar R, Lee D, Harary O, Holleran R, Zhang S, Revol C, Tran D, Shah R, Abernethy AP, Kolodziej M

June 2017

Abstract

ASCO Annual Meeting

Electronic Calculation of Quality Measures in the EMR is Highly Dependent on Data Capture in Structured Fields: The Oncology Care Model (OCM) Quality Reporting Experience

Hamrick J, Revol C, Parulkar R, Lemmers O, Gippetti J, Bauer-Levey N, Lee D, Fugaro A, Kolodziej M, Green R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

June 2017

Abstract

ASCO Annual Meeting

Adoption of Immunotherapy into Real World Practice: Insights from the Use of Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres A, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Racial Disparities in the Use of Programmed Death-1 Checkpoint Inhibitors

O’Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres A, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

June 2017

Abstract

ASCO Annual Meeting

Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer

Presley C, Chiang A, Longtine J, Soulos P, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy AP

June 2017

Abstract

ASCO Annual Meeting

Development and Validation of a Real-World Clinico-Genomic Database

Singal G, Miller P, Agarwala V, He J, Gossai A, Frank S, Bourque D, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Parker A, Guria A, Frampton G, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller V

June 2017

Abstract

ASCO Annual Meeting

Real-World Rates of Chemotherapy Use Near the End of Life (EOL) in Cancer Patients

Agarwala V, Kraut J, Gippetti J, Revol C, Peterson D, Fessele K, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

The NCCN-Flatiron Outcomes Database: Collaborative Evidence Development and Quality Improvement in Oncology

Agarwala V, Birnbaum B, Gippetti J, Talcott L, Kraut J, Bowser B, Delgado J, Nightingale C, Lvov M, Nussbaum N, Connolly D, Martineau J, Darius K, Fessele K, McClure J, Fitzgerald L, Carlson R, Abernethy AP

March 2017

Abstract

NCCN Annual Conference

Total Cost of Care in Patients with Advanced Non-Small Cell Lung Cancer Receiving Oral Targeted Therapy vs. Standard Therapy

Gabriel PE, Berman AT, Guttman D, Stetson R, Kruse G, Morrissette J, Agarwala V, Kraut J, Abernethy AP, Shulman LN, Evans T

March 2017

Abstract

Personalized Medicine Conference-Fusion

Chemotherapy Use Near End of Life (EOL): Measuring Real World Benchmarks

Kraut J, Gippetti J, Peterson D, Agarwala V, Revol C, Fessele K, Abernethy AP

March 2017

Abstract

ASCO Quality Care Symposium

March 2017

Abstract

ASCO Quality Care Symposium

Validation of Diagnosis Codes to Identify Side of Colon in an Electronic Health Record Registry

Luhn P, Kuk D, Carrigan G, Nussbaum N, Sorg R, Rohrer R, Tucker M, Arnieri B, Taylor M, Abernethy AP

January 2017

Abstract

ASCO Gastrointestinal Cancers Symposium

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

August 2016

Abstract

International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

Meeting of the Canadian Urological Association

June 2016

Abstract

ASCO Annual Meeting

Initiation and Adherence with Bone-Targeting Agents in US Men with Bone Metastases from Prostate Cancer

Butler A, Ceitin K, Hernandez RK, Overman R, Kim J, Reams D, Hirsch B, Abernethy AP, Liede A, Brookhart A

June 2016

Abstract

ASCO Annual Meeting

March 2016

Manuscript

Clinical Lung Cancer

March 2016

Manuscript

Future Oncology

November 2015

Manuscript

Clinical Epidemiology

September 2015

Abstract

European Cancer Congress

Real-World Bortezomib Usage Patterns Among Patients with Relapsed/Refractory Multiple Myeloma

Calkins G, Kohansimeh J, Krishna A, Green R, Curtis MD, Lindberg F, Jaskiw A, Larrabee K, Terry M, Feinstein RN, Plotkin L, Palladino ML, Nicacio L

June 2015

Abstract

EHA Learning Center

BRAF, KIT, and NRAS Testing Patterns and Results in Metastatic Melanoma

Abernethy AP, Fung C, Richardson P, Eisenberg D, Connolly D, Terry M, Feinstein RN, Tucker M, Miller C, Nicacio L

June 2015

Abstract

ASCO Annual Meeting